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Autosomal dominant polycystic kidney disease (ADPKD)
results from mutations in either PKD1 or PKD2 and
accounts for 10% of all patients on renal replacement
therapy. The kidney disease phenotype is primarily
characterized by cyst formation, but there are also
prominent interstitial changes (inflammation, apo-
ptosis, proliferation, and fibrosis). Using a model of
unilateral ischemia-reperfusion injury, we tested the
hypothesis that Pkd2 heterozygous kidneys are more
sensitive to injury and that this could lead to intersti-
tial inflammation and fibrosis. Baseline tubular pro-
liferation in heterozygous kidneys was twofold
higher than in wild-type kidneys. The magnitude and
duration of tubular and interstitial proliferative re-
sponses was consistently greater in injured heterozy-
gous compared with wild-type kidneys at all time
points. Conversely, tubular p21 expression in het-
erozygotes was lower at baseline and following injury
at all time points. Significantly more neutrophils and
macrophages were detected in injured Pkd2 heterozy-
gous kidneys at 2 days, correlating with increased
expression of the cytokines interleukin (IL)-1 and
keratinocyte-derived chemokine and resulting in in-
terstitial fibrosis at 28 days. We conclude that Pkd2
dosage influences both susceptibility and nature of
the repair responses following injury. Polycystin-2 is
therefore likely to play multiple roles in regulating
tubular cell viability, repair, and remodeling in the
mature kidney. (Am J Pathol 2009, 175:1493–1503; DOI:
10.2353/ajpath.2009.090227)
Autosomal dominant polycystic kidney disease (ADPKD)
results in kidney failure in 10% of all patients on renal
replacement therapy and is caused by mutations in PKD1
or PKD2.1,2 The ADPKD proteins, polycystin-1 (PC1) and
polycystin-2 (PC2), function as a heterodimeric complex
and have been shown to regulate multiple signaling path-
ways. These include intracellular Ca2, heterotrimeric
and monomeric G-proteins, protein kinase C, Janus ki-
nase and signal transducers and activators of transcrip-
tion, which in turn maintain normal tubular structure and
function (reviewed in Ref. 3). Although a weak pheno-
type-genotype correlation for renal survival has been re-
ported for PKD1, it is clear that nonallelic factors such as
genetic modifying loci and/or environmental factors exert
a greater influence on the cystic phenotype and probably
account for the marked intrafamilial phenotypic variability
often observed in ADPKD pedigrees.4–6
Cyst formation is a focal process and it has been
estimated that cysts arise from 1% of all nephrons
carrying a germline mutation of PKD1 or PKD2. The mu-
tational mechanism underlying cyst formation is thought
to require somatic mutation (“two hit” model); evidence of
somatic mutations in cystic cells isolated from PKD1 or
PKD2 kidneys has been shown.7 Nevertheless, there is
accumulating evidence that somatic mutation may not be
essential for cyst formation and that gene dosage could
be equally important. Thus, mice transgenic for PKD1 or
Pkd1 as well as Pkd1 hypomorphs have been shown to
develop renal cysts.8–11 Equally, other modifying genes
(eg, TSC2) and gender play key roles in determining
phenotypic severity probably by pathways independent
of the rate of somatic mutation.12–14 The cellular triggers
for cyst formation could differ between the developing
and mature kidney since recent reports of Pkd1 inactiva-
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tion using Cre-Lox mice have revealed marked differ-
ences in phenotype depending on the timing of Pkd1
deletion in the kidney.15–17
The presence of prominent interstitial changes in the
cystic kidney has been largely attributed to inflamma-
tory cell infiltration or matrix deposition secondary to
cyst growth. However in a recent study, we noted that
Pkd2 heterozygous mice (with minor cystic disease)
developed more prominent interstitial fibrosis than age-
matched wild-type mice.18 In this study, the degree of
interstitial fibrosis was significantly correlated not only to
cyst number but also to the tubular proliferative index (PI)
(detected in noncystic tubules). These results suggested
that interstitial fibrosis could occur independently of cyst
formation, possibly secondary to the increase in proliferat-
ing tubular cells or as the result of an increase in interstitial
inflammation. To test this hypothesis, we used a model of
transient unilateral ischemia-reperfusion injury (IRI) to inves-
tigate if Pkd2 haploinsufficiency could render the kidney
more susceptible to the development of interstitial scarring
following a single-shot injury.
Materials and Methods
Experimental Animals
Pkd2/ founder mice were obtained from Prof. S. Somlo
(Yale University). These mice carry a null allele (ws183) for
pkd2 resulting from homologous recombination at exon-1 of
the Pkd2 locus.19 They have been backcrossed onto a
C57BL/6 strain background for over 20 generations.
Experimental Groups
Female Pkd2 heterozygous or wild-type mice of 4 to 6
months of age (n  5–7/group) were housed at constant
temperature (21°C), humidity (45%) on a 12-hour light/
dark cycle and had free access to drinking water and
standard laboratory chow. Under Fluothane (ZENECA,
UK) anesthesia, the left renal artery and vein were ex-
posed using a flank incision and occluded using a non-
traumatic clamp for 25 minutes. Following ischemia, the
clamped kidney was reperfused for 2, 7, and 28 days
before harvest. After the stated time of reperfusion, the
ischemic (left) and nonischemic (right) kidney were re-
moved. Half of each kidney was fixed in 10% neutral-
buffered formalin, and the other half was snap frozen in
liquid nitrogen and stored at 80°C until further analysis.
All experimental procedures were performed according
to the rules and regulations as laid down by the Home
Office (Animal Scientific Procedures Act 1986, UK).
Human Nephrectomy Tissue
We analyzed stored archival kidney tissue (Department
of Histopathology, Northern General Hospital) that had
been formalin fixed and paraffin embedded. ADPKD kid-
ney sections (n  5–7) were derived from patients who
had undergone nephrectomy for various reasons, includ-
ing intractable pain, huge abdominal masses, pretrans-
plantation, recurrent hematuria, or cyst infection. As nor-
mal controls, tissue sections from the uninvolved pole of
kidneys removed because of a localized renal tumor
were used (n  4). All of the archived material (stored
before the year 2000) was dissociated, and therefore,
retrospective permission to use the tissue was not
appropriate.
Histomorphometric Analysis
H&E sections were used for analysis of cyst number and
mean cyst area. To differentiate between cysts and nor-
mal tubular profiles, only epithelial lined cavities of the
size of a glomerulus (6000 m2) or larger were counted
as cysts.13,18 The fibrosis score was estimated on Mas-
son Trichrome-stained sections by multiphase image
analysis as described previously.18,20 For each section,
10 randomized selected areas of cortex and medulla
were analyzed at 200 magnification.
A tubular injury score was evaluated on periodic acid-
Schiff-stained sections. The average internal cross-sec-
tional diameter of a normal cortical tubule was evaluated
on eight control kidney sections (left and right) from four
wild-type mice and estimated as 10 m. Necrotic tubules
were defined as those with loss of brush border and a
minimum dilatation of 1.5 times the average luminal di-
ameter of a normal tubule. All evaluation was performed
using touch count and arbitrary distance measurement
using AnalySIS5 software (Soft Imaging System], Ger-
many). A minimum of 100 tubules were counted per
section. The number of necrotic tubules was expressed
as a percentage of the total number of tubules counted.
Both kidneys were included in all histological analysis
and analyzed in a single-blinded manner.
Immunohistochemistry
Immunodetection for proliferating cell nuclear antigen
(PCNA), Ki-67, -SMA, F4/80, CD45, CD68, myeloperox-
idase, and p21 was performed on formalin-fixed paraffin-
embedded sections using previously published proto-
cols.18,20 The number of positive cells in each section
was counted in 10 consecutive nonoverlapping fields of
renal cortex and medulla at 200 magnification, and the
results expressed as mean  SE per mm2.20 The PI was
defined as the number of PCNA or Ki-67-positive cells
per section in 10 sequentially selected nonoverlapping
fields (200 magnification) of renal cortex and medulla,
expressed per mm2.
Costaining of F4/80 and PCNA was conducted using
primary antibodies raised in different species (rabbit,
mouse) as described previously.18 Bound antibody was
detected using a horseradish peroxidase-conjugated
goat anti-rabbit IgG for F4/80 staining and an alkaline
phosphatase-conjugated goat anti-mouse IgG for PCNA
staining. Diaminobenzidine and Vector Red (Vector Lab-
oratories, Peterborough, UK) were used as chromogens,
respectively. Only clearly definable nuclei with heavy/or
granular staining were counted as PCNA positive (red) and
expressed as a percentage of F4/80 positive (brown) cells.
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Assessment of Apoptosis
Apoptotic cells in kidney sections were detected by the
terminal deoxynucleotidyl transferase-mediated digoxige-
nin-deoxyuridine (dUTP) end labeling (TUNEL) method
(Chemicon International, Southampton, UK) following the
manufacturer’s protocol.20 The apoptotic index was defined
as the number of TUNEL-positive cells per section in 10
sequentially selected nonoverlapping fields (200 magnifi-
cation) of renal cortex and medulla, expressed per mm2.
Kidney Lysates
Snap-frozen kidneys were ground under liquid nitrogen and
homogenized in lysis buffer (2 M Tris-HCl and 1 mmol/L
EDTA supplemented with complete protease inhibitor tablet
(Roche, Welwyn Garden City, UK), 5 mol/L sodium vana-
date, and 5 mol/L sodium phosphate) using 10 strokes of
a Dounce homogenizer (Wheaton, Millville, NJ) followed by
sonication. Crude debris was sedimented using a low-
speed (1000  g) centrifugation and discarded. Lysates
were finally centrifuged in Beckman TL-100 ultracentrifuge
at (100,000  g) for 2 hours to give a cytosolic fraction
(supernatant) and a membrane pellet. Membrane pellets
were resuspended in 1% SDS to prepare the membrane
fraction. Total protein concentration was quantified using
the Bio-Rad DC Assay (Bio-Rad Laboratories UK, Hemel
Hempstead, UK).
Immunoblotting
The generation and detailed characterization of the poly-
cystin-1 (7e12) and polycystin-2 (p30) antibodies raised to
human sequence have been described in previous pa-
pers.13,21 Immunoblotting was performed on protein lysates
as described previously.22 In brief, membranes were incu-
bated overnight at 4°C with primary antibodies: mousemAb
to PCNA (Dako UK, Ely, UK), polycystin-1 (7e12), and poly-
cystin-2 (p30). These were incubated with an appropriate
horseradish peroxidase-linked secondary antibody: goat
anti-mouse IgG2a or IgG1 (Southern Biotechnology Associ-
ates, Cambridge, UK) or goat anti-rabbit (Dako UK). Mem-
branes were stripped and reprobed using an antibody
against the endoplasmic reticulum (ER) resident protein,
calnexin (BD Transduction Laboratories, Dorset, UK), to
control for protein loading and integrity. Band intensities of
PC1 and PC2 were quantified using a Bio-Rad GS-690
scanning densitometer using Molecular Analyst version 4
software and adjusted to that of calnexin as described
previously.22 Since PC2 and calnexin were sometimes de-
tectable as doublet bands, we quantified the upper band of
each protein because this was consistently present and
likely to represent the mature protein in each case.
Real-Time Quantitative PCR Assays
Total RNA was extracted from snap-frozen kidney tissue
using TRIzol, DNAase treated, and quantified using a fluo-
rescent nuclei acid assay (Quant-iT RiboGreen reagent;
Invitrogen). DNase-treated RNA (1.5 g) was reverse tran-
scribed using the Superscript II RT system (Invitrogen). All
samples were analyzed in triplicate and reverse transcribed
using the same master mix (SYBR Green; Stratagene) in a
single batch to avoid differences in the efficiency of the
Reverse Transcriptase (RT) reaction between samples. The
cDNA concentration wasmeasured to ensure equal loading
of template. Primer specificity was first validated by stan-
dard PCR to check that a single product of the right size
was obtained on agarose gel electrophoresis. For quantita-
tive PCR, a MX3000P Thermal Cycler (Stratagene) was
usedwith a cycle profile of 40 cycles at 95°C for 30 seconds
and 60°C for 1 minute. The number of template cDNA
molecules in each sample was determined by recording the
amplification cycle number during the exponential phase
(cycle threshold or CT). On the basis of this principle, the
starting number of template cDNA is inversely proportional
to CT. Standard curves were generated using a range of 1:3
serial dilutions by plotting CT against log of known standard
RNA concentrations. The reaction was optimized to obtain
an efficiency between 95 and 110%. The relative mRNA
concentration in each sample was calculated by extrapola-
tion from the standard curve and expressed in arbitrary
units.
Cytokine Measurements
Cytokines were assayed using a Bio-Plex murine 23-plex
microsphere assay (Bio-Rad) according to the manufactur-
er’s instructions. The assay was run on a Luminex 200
system using high Photomultiplier Tube (PMT) settings for
narrow range standard curve (system calibrated with CAL2
high RP1 target value). Lysates were diluted one in two with
Bio-Plex assay buffer before the assay. Results were ex-
pressed as pg/100 g protein.
Statistical Analysis
Values are expressed as means  SEM. Comparison
between groups was performed using the Mann-Whitney
U-test for nonparametric data. Correlation analyses used
the Spearman correlation test. A value of P  0.05 was
considered statistically significant.
Results
Cell Proliferation, Apoptosis, and Inflammation
in Human ADPKD Kidney
We first examined human ADPKD and normal kidney
tissue to assess changes in proliferation, apoptosis and
inflammation. Cell proliferation in human ADPKD kid-
ney was markedly increased in both tubular and inter-
stitial compartments using the marker PCNA, which
labels cycling cells (Supplemental Fig. S1, C and D,
see http://ajp.amjpathol.org). Few PCNA-positive cells
were visualized in the cyst lining, the majority of posi-
tive cells being found in undilated or dilated (but non-
cystic) tubular segments (Supplemental Fig S1B, see
http://ajp.amjpathol.org). Similarly, the number of apopto-
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tic cells in tubular segments was two to three times higher
that that in cyst lining (Supplemental Fig S1, F and G, see
http://ajp.amjpathol.org). There was a significant increase
in the interstitial apoptotic indexcomparedwith normal kidneys
(Supplemental Fig S1H, see http://ajp.amjpathol.org). The AD-
PKD interstitium was characterized by a noticeable in-
crease in surface area, inflammatory cells, and -smooth
muscle actin (-SMA)-positive fibroblasts (data not
shown). Approximately 20% of interstitial cells were CD68
positive, suggesting a prominent macrophage infiltrate in
these diseased kidneys (Supplemental Fig S1, J and K,
see http://ajp.amjpathol.org).
Baseline Tubular and Interstitial Proliferation in
Pkd2 Heterozygous and Wild-Type Kidneys
The baseline mean tubular PI was twofold higher in het-
erozygous mice (n  6) compared with age-matched
female wild-type (n  7) mice (left kidney (LK): 6.92 
0.70 versus 3.40  0.41, P  0.0047; right kidney (RK):
7.08  0.49 versus 3.95  0.41, P  0.0012). However,
there were no significant differences in interstitial PI, al-
though mean values were 40% higher in heterozygous
mice compared with wild-type (LK: 3.69  0.60 versus
2.61  0.32; RK: 3.88  0.51 versus 2.89  0.23).
Cell Proliferation Following IRI in Pkd2
Heterozygous and Wild-Type Kidneys
Following IRI, Pkd2/ kidneys demonstrated on average
a 1.5- to 2-fold greater increase in proliferating cells
(Ki-67 positive) compared with wild-type kidneys at 2
days postinjury (Figure 1; Supplemental Table 1, see
http://ajp.amjpathol.org). This increase was observed in
both tubular and interstitial compartments. In addition,
the magnitude and duration of the tubular and interstitial
proliferative response of the injured LK and uninjured RK
was clearly different between wild-type and heterozy-
gous animals (Figure 1). In wild-type mice, tubular PI
peaked at 2 days in the injured kidney but was not
significantly elevated at 7 days post reperfusion com-
pared with the uninjured or control kidneys (Figure 1, A
and C). In contrast, tubular PI in the injured heterozygous
kidneys showed an exaggerated peak in tubular PI at 2
days. In addition, tubular PI between injured and unin-
jured or control kidneys was significantly different up to
28 days postinjury (Figure 1, A, C, E). Similar differences
were observed for interstitial proliferation in both wild-
type and heterozygous kidneys (Figure 1, B, D, F). Of
interest, the tubular and interstitial PI of wild-type and
heterozygous injured kidneys remained significantly ele-
vated compared with control kidneys at 28 days but were
significantly higher in heterozygous kidneys (Figure 1, E
and F; Supplemental Table 1, see http://ajp.amjpathol.org).
PCNA expression by immunoblotting was approximately
threefold higher in heterozygous than wild-type injured kid-
neys at 2 days, consistent with the Ki-67 expression data
(Figure 1G). Representative images of Ki-67-positive cells
postischemia for both genotypes at each time point are
shown in Supplemental Fig S2 (see http://ajp.amjpathol.org).
The response of the uninjured wild-type and heterozy-
gous kidneys were similar following IRI. We observed a
Figure 1. Proliferative responses of tubular and
interstitial compartments in Pkd2 heterozygous
and wild-type mice following IRI. The PI (Ki-67
positive cells per mm2) for tubular and intersti-
tial compartments at different postreperfusion
periods is shown: 2 days (A and B); 7 days (C
and D); and 28 days (E and F). The contralateral
RK served as a nonischemic control for the proce-
dure. Values from control age and sex matched
kidneys are shown as open bars: baseline tubu-
lar PI was twofold higher in heterozygous kid-
neys compared with wild type (significance only
shown at 28 days for clarity). Tubular and inter-
stitial PI were significantly higher at all time
points in the injured LKs of heterozygous (/)
and wild type (/) compared with control
values (data not shown). In addition, values for
the heterozygous LK were significantly greater
than those for wild-type LK at all time points
(except for interstitial PI at 7 days, P  0.06).
Data shown are means  SEM of cell counts per
mm2 per kidney (n  5–7). P  0.05; P 
0.01; and P  0.001. G: Mean PCNA (36
kDa) expression at 2 days was threefold higher
in /LK compared with /LK. Calnexin
(90 kDa) served as a control for loading and
protein integrity.
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small but significant rise in tubular PI at 2 days only for
both genotypes compared with controls (Figure 1; Sup-
plemental Table 1, see http://ajp.amjpathol.org). No sig-
nificant changes were detected for interstitial PI in the
uninjured kidneys for both genotypes compared with
controls.
Leukocyte Accumulation and Macrophage
Infiltration Following IRI
Following IRI, we also noted a marked increase in leuko-
cyte (CD45) and macrophage (F4/80) accumulation in
the renal interstitium at all time periods examined (Figure
2, A–C). Once again, quantitative differences of two- to
threefold were noted between both genotypes with a
peak in the number of CD45 and F4/80 cells at 7 days
(Table 1). The number of F4/80 cells in injured heterozy-
gous kidneys was significantly greater than that seen in
wild-type kidneys at 2 days (Figure 2, A–C). At 7 days, the
proportion of proliferating macrophages (F4/80 cells that
were also PCNA-positive) was significantly greater in in-
jured heterozygous kidneys (Figure 2, D–F). Highly sig-
nificant correlations were found especially between the
F4/80 (r  0.87) or CD45 (r  0.83) counts and the
fibrosis score at 7 days (Table 2). There were no signifi-
cant differences in the number of F4/80 cells (2 days),
SMA-positive cells (28 days) and fibrosis (28 days) be-
tween the uninjured kidneys of both genotypes (Supple-
mental Fig S3, see http://ajp.amjpathol.org).
Fibroblast Activation and Interstitial Fibrosis
Following IRI
-SMA expression has been found to correlate with a
more activated fibroblastic phenotype and may precede
the onset of interstitial fibrosis.23 Occasional -SMA-pos-
itive cells were detected at 2 days postreperfusion in
either interstitium or glomeruli. There were more -SMA-
positive cells by 7 days in heterozygous kidneys following
injury and this was significantly different at 28 days (Fig-
ure 2, G–I). At this time point, we also detected a signif-
icant difference in the fibrosis score between heterozy-
gous and wild-type kidneys (Figure 2, J–L) and a highly
significant correlation between -SMA expression and
the fibrosis score (Table 2). An increase in macrophage
and proliferating macrophage infiltration as well as myo-
fibroblast (SMA) accumulation has been previously cor-
related with chronic kidney injury in the rat remnant kid-
ney model.23
Polycystin-1and Polycystin-2 Expression
Following IRI
In a previous study using a rat model of unilateral IRI, we
reported that renal Pc2 expression was increased follow-
ing ischemia.22 In that study, we were unable to assess
Pc1 expression because our PC1 antibody did not cross-
react with rat Pc1. In the present study, we found a
differential rise in Pc1 expression of between 1.4- and
1.7-fold in the LK compared with RK at 2 days—the
magnitude of this increase was not different between the
genotypes (Figure 3, A and B). Although baseline Pc2
expression was lower in the heterozygotes, a similar level
of increase in Pc2 expression (1.7- to 1.9-fold) was ob-
served in LK of both genotypes compared with the non-
ischemic RK at 2 days.
By quantitative PCR, pkd2 mRNA levels at 2 days
reperfusion were significantly lower in heterozygous non-
ischemic RK compared with wild-type RK reflecting the
difference in gene dosage (Figure 3C). Pkd1 mRNA lev-
els were the same in both genotypes. Both Pkd1 and
Pkd2 mRNA levels were significantly increased in both
wild-type and heterozygous LK. Relative to the RK, the
increases were between 1.6 and 1.8 times, values similar
to that found by immunoblotting (Figure 3B). This indi-
cates that the increase in Pc1 and Pc2 expression follow-
ing IRI is likely due to increased gene transcription and/or
mRNA stability. Nevertheless, Pkd2 mRNA levels in the
heterozygous LK were still 33% that of the wild-type LK
at 2 days postischemia.
p21 Expression Following IRI
p21 expression was examined by immunohistochemistry
in ischemic and control kidneys from both genotypes.
There was a significant difference in the pattern and
magnitude of tubular p21 expression between wild-type
and heterozygous ischemic kidneys (Figure 4, A and B;
Supplemental Table 1, see http://ajp.amjpathol.org). Wild-
type mice showed a significantly greater increase in p21
expression in the injured kidney at 2 days, and this rise
was maintained at 7 and 28 days postinjury. In contrast,
p21 expression in heterozygous mice showed a smaller
increase reaching significance only at 7 days (Figure 4B).
At each time point, the increase in p21 expression postin-
jury was lower in heterozygous kidneys (Supplemental
Table 1, see http://ajp.amjpathol.org). We examined
age-matched control sections (n  7) from both geno-
types and found significantly fewer p21 positive cells in
both kidneys of heterozygous (50%) compared with
wild-type mice (Figure 4B; Supplemental Table 1, see
http://ajp.amjpathol.org). These results are the exact
reverse of our findings with Ki-67-positive cells in con-
trol mice.
Tubular Injury Following IRI
The severity of tubular injury at 2 days post-IRI was as-
sessed by the number of necrotic tubules per section ex-
pressed as a percentage of the total number of tubules
counted. Examples of the most severely affected animals
from both genotypes are shown in Figure 4C. The mean
necrosis scores were 1.7 times higher in the ischemic het-
erozygotes compared with wild-type kidneys (/21.4 
6.1%, /12.9  3.4%; P  0.05), although a wide range of
severity was detected in both groups.
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Figure 2. Changes in macrophage infiltration, activated fibroblasts and interstitial fibrosis in Pkd2 heterozygotes and wild-type mice following IRI.
Wild-type (A, D, G, and J) and heterozygous (B, E, H, and K) kidneys were examined for F4/80 macrophages (A and B), the percentage of PCNA-positive
F4/80 macrophages (D and E), -SMA-positive fibroblasts (G and H), and collagen deposition (J and K). In heterozygous kidneys, the number of F4/80
macrophages was significantly increased at 2 days (C), and the number of doubly positive PCNA (red) - F4/80 (brown) cells at 7 days (F), respectively.
At 28 days, both -SMA-positive fibroblasts (I) and the overall fibrosis score (L) were significantly greater in heterozygous compared with wild-type LKs.
The white arrows indicate typical F4/80-positive cells and the black arrows double PCNA and F4/80-positive cells. Magnification, 400. Data shown are
means  SEM (n  5–7). P  0.05.
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Cytokine Release Following IRI
Because of the prominent inflammatory changes and result-
ant increase in interstitial fibrosis, we assayed for a variety of
cytokines in kidney tissue at 2 days reperfusion using a
commercial multiplex bead assay. Of 23 cytokines mea-
sured, 7 (granulocyte-CSF, keratinocyte-derived chemo-
kine, regulated on activation normal T cell expressed and
secreted, IL-1, IL-2, IL-9, IL-12p40) were within the detect-
able range. Of these, IL-1 and KC (or CXCL1) were both
significantly elevated in injured heterozygous kidneys com-
pared with wild-type (Figure 5A). The levels in nonoperated
age-matched wild-type and heterozygous control kidney
lysates (n  3–4) were largely below the limit of detection
(data not shown).
Neutrophil Infiltration Following IRI
In view of the increase in IL-1 and KC observed, we also
evaluated the degree of interstitial and glomerular neu-
trophil infiltration detectable. As shown in Figure 5B, sig-
nificantly more neutrophils were detected in the glomeruli
and interstitium of heterozygous compared with wild-type
LK at 2 days postinjury.
Discussion
Recent studies have highlighted subtle phenotypic
changes in Pkd1 and Pkd2 heterozygous mice that ap-
pear to correlate to a reduction in gene dosage without
the requirement for somatic mutation. For instance, there
Figure 3. Expression of PC1 and PC2 in Pkd2 heterozygotes and wild-type
mice following IRI. A: Immunoblotting for PC1 and PC2 in membrane
fractions prepared from both kidneys at 2 days postinjury (n  3). Highly
specific antibodies to PC1 (7e12) and PC2 (p30) were used. Representative
blots for PC2 for short (30 seconds) and long (5 minutes) exposures are
shown to illustrate the differences in PC2 protein levels between both
genotypes most apparent at shorter exposures. Calnexin (90 kDa) was used
to demonstrate equivalent loading between lanes. B: PC1 expression (500
kDa) was increased by up to twofold in the postischemic LK compared with
the nonischemic RK in both genotypes (/1.44  0.13; /1.72  0.58).
Although baseline PC2 (110 kDa) was lower in Pkd2 heterozygous kidneys,
a similar fold increase in PC2 expression was observed in both genotypes
following IRI (/1.65  0.46; /1.93  0.79). Bars represent mean 
SEM values from three separate experiments. C: Renal Pkd1 mRNA and Pkd2
mRNA levels were significantly increased at 2 days reperfusion in the isch-
emic LK relative to the nonischemic RK. However, as predicted, mean levels
of Pkd2 were at least 50% lower in both heterozygous kidneys compared
with wild-type equivalents. AU, arbitrary units. Values are means  SEM
(n  9). P  0.001.
Table 1. Effect of IRI on Apoptosis (TUNEL), Macrophage Infiltration (F4/80), and Leukocyte Accumulation (CD45)
Parameter LK/ RK/ LK/ RK/ Mann-Whitney P value
2 days
TUNEL (tubular cells/mm2) 1.9  0.6 0.15  0.04 0.86  0.27 0.18  0.06 0.2949
F4/80 (cells/mm2) 97.7  14.8 32.4  9.0 40.4  14.6 25.8  8.6 0.0350
CD45 (cells/mm2) 315.8  93.4 146.8  34.04 175.6  35.9 182.1  75.8 0.366
7 days
TUNEL (tubular cells/mm2) 3.3  1.9 0.03  0.03 1.5  1.2 0.05  0.03 0.5884
TUNEL (interstitial cells/mm2) 1.17  0.4 0.1  0.1 1.0  0.7 0.0  0.0 0.4848
F4/80 (cells/mm2) 400.9  163.6 99.1  44.5 236.0  113.1 72.4  30.5 0.4848
CD45 (cells/mm2) 816.9  304.8 184.9  79.7 446.6  170.4 213.0  80.7 0.4848
28 days
TUNEL (tubular cells/mm2) 0.4  0.1 0.05  0.03 0.1  0.04 0.02  0.02 0.0727
TUNEL (interstitial cells/mm2) 0.3  0.01 0.02  0.02 0.04  0.02 0.02  0.02 0.2303
F4/80 (cells/mm2) 330.7  79.5 179.7  34.4 142.0  29.7 137.6  32.5 0.1636
CD45 (cells/mm2) 387.3  95.3 193.3  33.1 168.2  36.7 150.7  49.7 0.1091
LK/ versus LK/.
Table 2. Correlations between Fibrosis Score and
Other Cellular Responses at 7 and 28 days
Postreperfusion
Fibrosis score
Parameter P r
7 days
-SMA (cells/mm2) 0.0207* 0.4693
F4/80 (cells/mm2) 0.0001*** 0.8653
CD45 (cells/mm2) 0.0001*** 0.8287
Tubular PI (cells/mm2) 0.001** 0.6284
Interstitial PI (cells/mm2) 0.0278* 0.4489
28 days
-SMA (cells/mm2) 0.0078** 0.5516
F4/80 (cells/mm2) 0.0185* 0.4975
CD45 (cells/mm2) 0.0035** 0.5942
Tubular PI (cells/mm2) 0.0008*** 0.6623
Interstitial PI (cells/mm2) 0.0059** 0.5675
P  0.05, number of  indicates level of significance.
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is an increase in tubular PI in Pkd1 and Pkd2 kidneys that
precedes cyst formation.15,17,18 For Pkd2, a highly signif-
icant correlation was observed between the tubular PI
and the presence of interstitial fibrosis in the kidneys of
heterozygous mice.18 A syndrome of inappropriate an-
tidiuresis has been reported in Pkd1 heterozygous
mice.24 Similarly, Pkd2 heterozygous mice are more
prone to developing intracranial vascular abnormalities
when rendered hypertensive by salt-loading; freshly dis-
sociated vascular smooth muscle cells isolated from
Figure 4. The severity of tubular injury is increased in Pkd2 heterozygous mice compared with wild-type following IRI. A: Representative panels showing
p21-positive tubular cells for both genotypes at 2 days post-IRI. Some background apical and cytoplasmic staining was seen with this antibody, but only nuclear
positive cells (arrows) were counted. Magnification, 400. B: The number of p21 nuclear positive tubular cells was quantified in age-matched control kidneys
of both genotypes (white bars) and at 2, 7, and 28 days following IRI (black bars). There were significantly fewer p21-positive cells in heterozygous control kidneys
compared with wild-type (significance shown on 28 days only for clarity). At all time points following reperfusion, tubular p21 expression was significantly lower
in the heterozygous LK compared with wild-type LK. P  0.05, P  0.01. C: The panels show representative periodic acid-Schiff-stained kidney sections from
the most severely affected animals of both genotypes (n  6–7) with arrows indicating dilated tubules, some with cell debris and proteinaceous casts.
Magnification, 400. The mean percentage of necrotic tubules per section at 2 days post-IRI was greater in heterozygous mice but did not reach statistical
significance.
Figure 5. Cytokine expression and neutrophil
infiltration is increased in Pkd2 heterozygous
mice compared with wild-type following IRI. A:
Significantly greater increases in IL-1 and KC
were detectable in the postischemic LK of het-
erozygous mice compared with their wild-type
littermates at 2 days. Levels of other detectable
cytokines, including IL-12p40, were not differ-
ent between genotypes and unchanged by isch-
emia. B: There were a greater number of neu-
trophils (myeloperoxidase-positive cells) at 2
days in both interstitium and glomeruli of post-
ischemic LK of heterozygous mice compared
with their wild-type littermates. P  0.05 (n 
5–7).
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these mice have altered Ca2 regulation.25 Finally, pkd2
heterozygous mice have been reported to have a short-
ened life span compared with their wild-type littermates
although the cause of their reduced longevity is
unexplained.26
Our present study adds further evidence that the hap-
loinsufficient state in PKD2 is not benign but may render
the kidney more susceptible to tubular injury and an
exaggerated repair response (Figure 6). The repair re-
sponse in terms of proliferation, apoptosis, and inflam-
mation was increased both in magnitude and duration
following a single-shot ischemic stimulus. This in turn led
to permanent structural (fibrosis) and presumably func-
tional changes in the Pkd2/ kidney. A likely interpreta-
tion of these results is that normal levels of PC2 are
required to regulate tissue repair following injury.22 Al-
though both Pkd1 and Pkd2 gene expression were sim-
ilarly increased by up to twofold in both genotypes at 2
days following IRI, levels of Pkd2 mRNA remained signif-
icantly lower in both heterozygous kidneys (Figure 3C).
We hypothesize that both the baseline level of Pc2 in the
kidney at the time of the injury (see later) as well as an
appropriate magnitude of increase in response to injury is
critical to the regulation of the subsequent repair re-
sponse. In this study, we observed a twofold difference in
baseline tubular PI between wild-type and heterozygous
kidneys, a lower difference than what we previously re-
ported (5- to 10-fold) in the same model.18 However, the
latter study was performed on older mice (9 to 12 months
of age) of both genders, factors that could explain the
differences observed. Of interest, two studies in Pkd1
heterozygous mice have reported increases in baseline
tubular PI of two- to fourfold in animals of up to 5 months
of age, results similar to ours.15,17 These results and ours
support the idea that dosage of Pkd1 or Pkd2 controls the
level of basal cell turnover in the kidney.
In this study, we chose to compare the cellular re-
sponses of injured to the uninjured kidney between two
genotypes by using a model of unilateral renal ischemia.
Our results demonstrate that differences in magnitude
and duration for the tubular and interstitial proliferative
response following injury can be related to gene dosage.
A potential disadvantage of our approach is that the
uninjured kidneys could respond to injury of the contralat-
eral kidney in a genotype-dependent manner. Indeed,
although there were still differences in tubular PI between
the uninjured kidneys from both wild-type and heterozy-
gous mice, they were smaller than that observed in con-
trol mice, suggesting that this could be the case. None-
theless, none of these differences was statistically
significant (Supplemental Table 1 and Supplemental Fig-
ure 3, see http://ajp.amjpathol.org). An alternative ap-
proach would have been to use age- and sex-matched
sham-operated mice for both wild-type and heterozygous
mice without renal injury at each time point.
One possible link between PC2 and tissue repair is
through the cyclin-dependent kinase inhibitor, p21, which
has multiple effects on proliferation and apoptosis in
different cells. p21 has been reported to regulate cell
cycle progression from G1 to S, to inhibit DNA polymer-
ase activity by direct binding to PCNA, and to inhibit
apoptosis.27 An important link to PKD pathogenesis was
the finding that p21 is transcriptionally regulated by PC1
(and dependent on PC2) via the Janus kinase-signal
transducers and activators of transcription 1 pathway. At
E15.5, p21 levels in Pkd1 null embryos were greatly
reduced compared with wild-type controls, whereas
basal p21 levels in Pkd1 heterozygotes were un-
changed.28 p21 has been reported to be induced by IRI
(bilateral renal clamping) in C57BL/6 mice primarily in
tubular cells.29 The induction of p21 following IRI may be
protective because kidney function and mortality were
worse in p21-knockout mice despite an increase in
PCNA-positive cells.27 In this study, we found that p21
expression was 50% lower in control kidneys from Pkd2
heterozygotes compared with wild-type mice (Figure 4B).
In addition, tubular p21 expression remained significantly
lower at all times postreperfusion in Pkd2 heterozygotes
at a time when the tubular PI was two to three times
higher. Suboptimal increases in p21 following injury
(such as in Pkd2 mice) could also lead to inappropriate
entry of damaged cells into the cell cycle rather than cell
cycle arrest with consequent cell loss by apoptosis and
necrosis. To our knowledge, this is the first study to report
p21 expression in Pkd2 kidneys and that basal p21 ex-
pression is influenced by Pkd2 dosage.
The increase in kidney fibrosis at 28 days following IRI
in Pkd2 heterozygote kidneys was an unexpected find-
ing. Fibrosis was preceded by an early and persistent
increase in interstitial infiltrates (neutrophils, macro-
phages, and leukocytes), which are likely to have been of
pathogenic relevance. There was a significant increase in
neutrophils and F4/80 macrophages by 2 days postin-
jury, indicating that elevated cytokine release by resident
or infiltrating cells could be important (Figures 2 and 5).
Using cytokine assays, we found significant differences
between heterozygous and wild-type kidneys at 2 days
Figure 6. A multistep model of disease pathogenesis in ADPKD. Hypothet-
ical scheme of the interaction between gene dosage (Pkd2 haploinsuffi-
ciency) and environmental factors (injury) in the development of cysts and
interstitial fibrosis. The dotted lines represent likely recruitment of inflam-
matory cells resulting from cytokines release by injured and/or proliferating
tubular, fibroblast, and endothelial cells. Not shown are potential pathogenic
links between proliferating tubular cells and fibroblast proliferation (para-
crine growth factors) or interstitial fibrosis (interstitial collagen secretion and
degradation). Baseline tubular proliferation was increased by twofold in
Pkd2 heterozygous kidneys correlating to a proportional reduction in p21
expression. Increased cell cycling could predispose cells to acquiring somatic
mutations and susceptibility to additional stochastic events necessary to
trigger cyst initiation. However, overall susceptibility is likely to depend on
the state of cellular differentiation and/or proliferative potential. Cyst expan-
sion may depend on the acquisition of somatic mutations in other nonallelic
genes and the influence of other soluble factors.
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postinjury for IL-1 and KC (Figure 5). Both cytokines are
induced early following IRI and known to be critical for
neutrophil recruitment in the postischemic kidney.30,31
These findings suggest that the transcriptional regulation
of key cytokine genes such as IL-1 and KC could be
altered in Pkd2-deficient animals and be unmasked by
IRI. Future studies will seek to clarify the time course of
these events and also the underlying mechanism. Our
results are consistent with previous reports of detectable
cytokines in human PKD cyst fluid, including IL-1 and
KC/Gro-.32,33
Three recent articles have highlighted a clear differ-
ence in phenotypic severity depending on the timing of
tissue-specific Pkd1 inactivation using Cre-Lox technol-
ogy.15–17 If Pkd1 is inactivated during development, cyst
development is severe. Conversely, a mild phenotype is
observed if Pkd1 is deleted in the mature organ. These
studies differ in their evaluation of the critical window of
susceptibility. Nonetheless, they demonstrate that the ab-
sence of Pc1 is insufficient by itself to trigger a cystic
phenotype. An additional stimulus such as injury seems
to be required to trigger cystic transformation in cells
predisposed by their particular differentiation status or
proliferative potential.16,34,35 On the basis of our results
and that of others, we propose a multistep model for
cystogenesis as summarized in Figure 6. In this model,
there is increased cell cycling as a result of heterozygos-
ity of Pkd2 or Pkd1 (first hit) in part related to p21 defi-
ciency. This could lead to an increased frequency of
somatic mutation (second hit) and/or susceptibility to
stochastic events during the cell cycle. Environmental
triggers such as ischemia, irradiation, or toxic injury could
exaggerate this process by further stimulating the cycle
of proliferation and repair. Moreover, the exaggerated
release of cytokines could lead independently to inflam-
mation and fibrosis, prominent features of other rodent
cystic models.36,37 Finally, we propose that somatic mu-
tations in other nonallelic genes (third hit) could be im-
portant modifiers of cyst expansion.38 Their interactions
with stochastic events and other stimuli (eg, growth fac-
tors, peptides, hormones) could further influence the rate
of cyst expansion.20,39 We did not observe an increase in
cyst formation in Pkd2 heterozygous kidneys up to 28
days following injury, although in some mice, marked
tubular dilatation was seen (Figure 4C). In this model, it
seems likely that cyst formation occurs exclusively on a
cellular recessive background as previously shown.18,19
It would be interesting to examine if adult Pkd2 condi-
tional null kidneys develop more cysts in response to
tubular injury. During the submission and review of this
article, two groups have reported that tubular injury (IRI or
toxic) does exacerbate cystic disease in adult Pkd1 con-
ditional knockout mice.40,41
Recent studies in PKD1 and PKD2 pedigrees have
highlighted the relatively minor role of specific alleles but
emphasized the major roles of modifying genes, gender,
environmental factors, and their interactions in determin-
ing individual phenotypic severity.5,6,42 Our data high-
light for the first time the critical role that a single envi-
ronmental factor can play in determining disease severity
on a predisposing genetic background in a syntenic
ADPKD model.
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